Logo image of SENS

SENSEONICS HOLDINGS INC (SENS) Stock Fundamental Analysis

USA - NYSEARCA:SENS - US81727U1051 - Common Stock

0.4485 USD
0 (-0.75%)
Last: 9/16/2025, 10:35:00 AM
Fundamental Rating

2

Taking everything into account, SENS scores 2 out of 10 in our fundamental rating. SENS was compared to 191 industry peers in the Health Care Equipment & Supplies industry. The financial health of SENS is average, but there are quite some concerns on its profitability. SENS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SENS has reported negative net income.
SENS had a negative operating cash flow in the past year.
SENS had negative earnings in 4 of the past 5 years.
In the past 5 years SENS always reported negative operating cash flow.
SENS Yearly Net Income VS EBIT VS OCF VS FCFSENS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -45.39%, SENS is not doing good in the industry: 64.40% of the companies in the same industry are doing better.
The Return On Equity of SENS (-72.01%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -45.39%
ROE -72.01%
ROIC N/A
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SENS Yearly ROA, ROE, ROICSENS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

SENS's Gross Margin of 17.77% is on the low side compared to the rest of the industry. SENS is outperformed by 80.63% of its industry peers.
SENS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SENS Yearly Profit, Operating, Gross MarginsSENS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K

More info and screens

4

2. Health

2.1 Basic Checks

SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SENS has more shares outstanding
SENS has more shares outstanding than it did 5 years ago.
SENS has a worse debt/assets ratio than last year.
SENS Yearly Shares OutstandingSENS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
SENS Yearly Total Debt VS Total AssetsSENS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -5.37, we must say that SENS is in the distress zone and has some risk of bankruptcy.
SENS's Altman-Z score of -5.37 is on the low side compared to the rest of the industry. SENS is outperformed by 71.20% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that SENS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.37, SENS perfoms like the industry average, outperforming 47.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -5.37
ROIC/WACCN/A
WACC8.55%
SENS Yearly LT Debt VS Equity VS FCFSENS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

2.3 Liquidity

A Current Ratio of 9.58 indicates that SENS has no problem at all paying its short term obligations.
SENS has a Current ratio of 9.58. This is amongst the best in the industry. SENS outperforms 91.10% of its industry peers.
SENS has a Quick Ratio of 9.26. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
SENS has a better Quick ratio (9.26) than 92.15% of its industry peers.
Industry RankSector Rank
Current Ratio 9.58
Quick Ratio 9.26
SENS Yearly Current Assets VS Current LiabilitesSENS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.08% over the past year.
The Revenue has been growing slightly by 5.94% in the past year.
The Revenue has been growing slightly by 1.08% on average over the past years.
EPS 1Y (TTM)23.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%36.67%

3.2 Future

SENS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.21% yearly.
Based on estimates for the next years, SENS will show a very strong growth in Revenue. The Revenue will grow by 50.35% on average per year.
EPS Next Y36.25%
EPS Next 2Y21.48%
EPS Next 3Y17.18%
EPS Next 5Y17.21%
Revenue Next Year63.54%
Revenue Next 2Y68.11%
Revenue Next 3Y64.58%
Revenue Next 5Y50.35%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SENS Yearly Revenue VS EstimatesSENS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
SENS Yearly EPS VS EstimatesSENS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SENS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SENS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SENS Price Earnings VS Forward Price EarningsSENS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SENS Per share dataSENS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

SENS's earnings are expected to grow with 17.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.48%
EPS Next 3Y17.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SENS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENSEONICS HOLDINGS INC

NYSEARCA:SENS (9/16/2025, 10:35:00 AM)

0.4485

0 (-0.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners10.87%
Inst Owner Change75.04%
Ins Owners3.5%
Ins Owner Change5.16%
Market Cap365.38M
Analysts76.67
Price Target1.46 (225.53%)
Short Float %6.6%
Short Ratio7.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.35%
Min EPS beat(2)1.96%
Max EPS beat(2)14.75%
EPS beat(4)3
Avg EPS beat(4)9.2%
Min EPS beat(4)-14%
Max EPS beat(4)34.09%
EPS beat(8)6
Avg EPS beat(8)7.97%
EPS beat(12)7
Avg EPS beat(12)-0.74%
EPS beat(16)11
Avg EPS beat(16)63.45%
Revenue beat(2)2
Avg Revenue beat(2)9.27%
Min Revenue beat(2)8.25%
Max Revenue beat(2)10.29%
Revenue beat(4)4
Avg Revenue beat(4)6.13%
Min Revenue beat(4)2.48%
Max Revenue beat(4)10.29%
Revenue beat(8)7
Avg Revenue beat(8)5.36%
Revenue beat(12)10
Avg Revenue beat(12)4.93%
Revenue beat(16)11
Avg Revenue beat(16)2.84%
PT rev (1m)1.24%
PT rev (3m)-28.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)38.9%
EPS NY rev (1m)20.78%
EPS NY rev (3m)20.78%
Revenue NQ rev (1m)-1.73%
Revenue NQ rev (3m)-17.14%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)2.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.35
P/FCF N/A
P/OCF N/A
P/B 3.86
P/tB 3.89
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.03
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.39%
ROE -72.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.77%
FCFM N/A
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.67%
Cap/Sales 1.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.58
Quick Ratio 9.26
Altman-Z -5.37
F-Score5
WACC8.55%
ROIC/WACCN/A
Cap/Depr(3y)70.29%
Cap/Depr(5y)48.74%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y36.25%
EPS Next 2Y21.48%
EPS Next 3Y17.18%
EPS Next 5Y17.21%
Revenue 1Y (TTM)5.94%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%36.67%
Revenue Next Year63.54%
Revenue Next 2Y68.11%
Revenue Next 3Y64.58%
Revenue Next 5Y50.35%
EBIT growth 1Y11.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.93%
EBIT Next 3Y12.25%
EBIT Next 5YN/A
FCF growth 1Y21.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.05%
OCF growth 3YN/A
OCF growth 5YN/A